Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $313K invested in Sonnet BioTherapeutics in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 11 closing their positions.
Holders
9
Holders Change
-10
Holders Change %
-52.63%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$93K |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$47K |
| 3 |
3
Morgan Stanley
New York
|
$2K |
